AU Patent

AU2010231630B2 — Medical composition for treatment or prophylaxis of glaucoma

Assigned to Ube Corp · Expires 2015-02-12 · 11y expired

What this patent protects

Provided is a pharmaceutical composition for treating or preventing glaucoma, comprising a pyridylamino acetic acid compound represented by general formula (1) or a pharmacologically acceptable salt thereof as an active ingredient. In formula (1), R

USPTO Abstract

Provided is a pharmaceutical composition for treating or preventing glaucoma, comprising a pyridylamino acetic acid compound represented by general formula (1) or a pharmacologically acceptable salt thereof as an active ingredient. In formula (1), R

Drugs covered by this patent

Patent Metadata

Patent number
AU2010231630B2
Jurisdiction
AU
Classification
—
Expires
2015-02-12
Drug substance claim
No
Drug product claim
No
Assignee
Ube Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.